WIN Consortium  WIN 聯(lián)合會(huì) www.winconsortium.org 
WIN 聯(lián)合會(huì)由得克薩斯大學(xué)MD Anderson癌癥中心（美國(guó)）和Gustave Roussy研究所（法國(guó)）于2010年發(fā)起，是學(xué)術(shù)界、制藥、生物技術(shù)、健康保健IT和患者權(quán)益領(lǐng)域29家領(lǐng)先組織的全球性網(wǎng)絡(luò)，旨在通過(guò)世界各地的臨床試驗(yàn)和研究課題，開(kāi)發(fā)、應(yīng)用基于基因組的癌癥研究中最具前景的進(jìn)展，加快抗癌新藥向臨床轉(zhuǎn)化的步伐、降低成本。WIN是非政府、非營(yíng)利組織，總部設(shè)在巴黎。
 
Initiated in 2010 by the University of Texas MD Anderson Cancer Center (USA) and the Institut Gustave Roussy (France), the WIN Consortium is a global network of 29 leading organizations from the academic, pharmaceutical, biotechnology, healthcare IT, and patient advocacy sectors working to accelerate the pace and reduce the cost of translating novel cancer treatments to the bedside by developing and applying, through worldwide clinical trials and research projects, the most promising advances in genomic-based cancer research. WIN is a non-governmental, not-for-profit organization headquartered in Paris.